Results

Total Results: 15 records

Showing results for "anticoagulant prophylaxis".

1. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
   January 01, 1996 - adults There is insufficient evidence to determine whether the proven benefits of routine aspirin prophylaxis … The association between aspirin prophylaxis and reduction in first MI was accentuated in women who currently … The success of aspirin prophylaxis in persons who have documented disease (secondary prevention) is felt … At the present time, data are insufficient to support or oppose the use of aspirin prophylaxis for the … The Salt Collaborative Group Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis

2. Archived: Published Comments and Response: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/published-comments-and-response/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
   October 15, 2009 - Mohan and colleagues regarding the USPSTF recommendation on aspirin prophylaxis for the prevention of

3. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
   January 01, 2002 - At that time, the Task Force found insufficient evidence to recommend for or against routine aspirin prophylaxis … Concomitant use of other nonsteroidal anti-inflammatory agents or anticoagulants further increased risk … Aspirin for the Primary Prevention of Cardiovascular Events 24 Adults without known CVD Aspirin prophylaxis

4. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
   April 11, 2016 - 34 recommend the use of low-dose aspirin for cardiovascular (including but not specific to stroke) prophylaxis

5. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
   April 11, 2016 - In terms of safety, some medications (for example, antiplatelet or anticoagulant drugs) may be considered … population-based, observational studies in which the uptake, continuation, and discontinuation of aspirin prophylaxis

6. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
   January 15, 2002 - At that time, the Task Force found insufficient evidence to recommend for or against routine aspirin prophylaxis … Concomitant use of other nonsteroidal anti-inflammatory agents or anticoagulants further increased risk

7. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: USPSTF Recommendation Statement (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/by8VJVre6h6BmadrGxaFMM
   April 01, 2016 - recommend the use of low-dose aspirin for cardiovas- cular (including but not specific to stroke) prophylaxis

8. Archived: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
   March 15, 2009 - Uncontrolled hypertension and concomitant use of anticoagulants also increase the risk for serious bleeding … Association, the American Heart Association further recommended the use of aspirin for cardiovascular prophylaxis

9. The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/pnyU5fxhdBUtCdvJ3GyqzR
   March 01, 2007 - Aspirin chemo- prophylaxis of colorectal cancer was the focus of 8 case– control studies (17–24), 7 cohort … Antiplatelet agents and anticoagulants for hyperten- sion. … other major disease Exclusion criteria: Sensitivity to aspirin; aspirin use �1 time/wk; use of oral anticoagulants

10. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - bleeding risk either due to risk factors (smoking, uncontrolled hypertension) or co-medication with anticoagulants … Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular

11. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
    April 01, 2016 - In terms of safety, some medications (for example, antiplatelet or anticoagulant drugs) may be considered … population-based, observational studies in which the uptake, continuation, and discon- tinuation of aspirin prophylaxis

12. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
    May 06, 2022 - bleeding risk either due to risk factors (smoking, un- controlled hypertension) or co-medication with anticoagulants … Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular

13. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
    March 01, 2009 - Uncontrolled hypertension and concomitant use of anticoagulants also increase the risk for serious bleeding … Association, the American Heart Association further recommended the use of aspirin for cardiovascular prophylaxis

14. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular

15. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Njxn2r3qtWKdBf2_VhS2Aw
    April 01, 2016 - Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovas- cular